Biomarkers in your clinical development programs--will the benefits outweigh the costs? Our longstanding relationship with the FDA and industry puts us in a unique position to address this question. Our consulting practice uses unique modeling and visualization techniques developed during six years of working with the FDA on biomarkers in clinical development.
→
Put your modeling and simulation tools into the state-of-the-art software platform that we developed with the FDA. Scientifically capable, computationally able, web-based, and scalable, the APG software platform will support your modeling and simulation needs today, into the future, locally and globally.
→
APG produces webinars that examine modern clinical trials design and improved R&D productivity from an analytical perspective. Our customers tells us that APG webinars foster intelligent discussions in their companies that span disciplines and encourage innovative thinking.
→
